Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cotinine effects on nicotine metabolism

S Zevin1, P Jacob, N Benowitz

  • 1Division of Clinical Pharmacology and Experimental Therapeutics, San Francisco General Hospital Medical Center, California 94110, USA.

Clinical Pharmacology and Therapeutics
|June 1, 1997
PubMed
Summary

Cotinine does not inhibit nicotine metabolism or lower nicotine clearance in smokers. Cotinine levels can quantify environmental tobacco exposure, as its half-life differs from nicotine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Standardized Electric-Field-Resolved Molecular Fingerprinting.

Analytical chemistry·2024
Same author

Challenges in the management of people with diabetes and cancer.

Diabetic medicine : a journal of the British Diabetic Association·2019
Same author

Report of second case and clinical and molecular characterization of Eiken syndrome.

Clinical genetics·2018
Same author

Co-morbidity in Attention-Deficit Hyperactivity Disorder: A Clinical Study from India.

East Asian archives of psychiatry : official journal of the Hong Kong College of Psychiatrists = Dong Ya jing shen ke xue zhi : Xianggang jing shen ke yi xue yuan qi kan·2017
Same author

Renal dysfunction in primary hyperparathyroidism; effect of Parathyroidectomy: A retrospective Cohort Study.

International journal of surgery (London, England)·2016
Same author

Diagnostic accuracy of an IgM enzyme-linked immunosorbent assay and comparison with 2 polymerase chain reactions for early diagnosis of human leptospirosis.

Diagnostic microbiology and infectious disease·2016

Area of Science:

  • Pharmacology
  • Toxicology

Background:

  • Smokers exhibit significantly reduced nicotine clearance and half-life compared to nonsmokers.
  • Cotinine, the primary nicotine metabolite, accumulates with regular smoking.
  • Nicotine and cotinine share a common liver enzyme for metabolism, suggesting potential interaction.

Purpose of the Study:

  • To investigate whether cotinine inhibits nicotine metabolism.
  • To determine if cotinine influences nicotine clearance in smokers.

Main Methods:

  • A randomized, double-blind, placebo-controlled crossover study involving 12 healthy nonsmokers.
  • Intravenous infusions of deuterium-labeled nicotine-d2 and cotinine-d4 were administered.
  • Subjects received either oral cotinine treatment or a placebo, with pharmacokinetic parameters analyzed.

Main Results:

  • Oral cotinine administration achieved plasma levels comparable to heavy smokers.
  • Cotinine did not affect the disposition kinetics or clearance of nicotine.
  • The half-life of cotinine derived from nicotine was longer than administered cotinine, indicating tissue nicotine release.

Conclusions:

  • Cotinine is not the cause of reduced nicotine clearance in smokers.
  • Cotinine pharmacokinetics in nonsmokers are similar to smokers, validating its use for environmental tobacco exposure assessment.
  • Slow nicotine release from tissues likely explains the prolonged cotinine half-life observed in some individuals.

Related Experiment Videos